Sleep Medicine Reviews
Volume 6, Issue 1 , Pages 55-67 , February 2002

Serotonin and sleep

References 

  1. Adrien J. The serotonergic system and sleep–wakefulness regulation. In:  Kales A editors. Handbook of Experimental Pharmacology. Berlin: Springer; 1995;p. 91–116
  2. Bjorvatn B, Ursin R. Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions. Rev Neurosci. 1998;9:265–273
  3. Portas CM, Bjorvatn B, Ursin R. Serotonin and the sleep–wake cycle: special emphasis on microdialysis studies. Progr Neurobiol. 2000;60:13–35
  4. Morin LP. Serotonin and the regulation of mammalian circadian rhythmicity. Ann Med. 1999;31:12–33
  5. Amin AH, Crawford TBB, Gaddum JH. The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J Physiol. 1954;126:596–618
  6. Koella W. Neurohumoral aspects of sleep control. Biol Psychiatry. 1969;1:161–177
  7. Koella WP, Czicman JS. Mechanism of the EEG-synchronizing action of serotonin. Am J Physiol. 1966;211:926–994
  8. Feldman PD. Electrophysiological effects of serotonin in the solitary tract nucleus of the rat. Naunyn-Schiedeberg's Arch Pharmacol. 1994;349:447–454
  9. Reinosobarbero F, Deandres I. Effects of opioid microinjections in the nucleus of the solitary tract on the sleep–wakefulness cycle states in cats. Anesthesiology. 1995;82:144–152
  10. Dahlström A, Fuxe K. Evidence for the existence of monoamine neurones in the central nervous system. I . Demonstration of monoamines in the cell bodies of brain stem neurones. Acta Physiol Scand. 1964;62:
  11. Andén NE, Dahlström A, Fuxe K, Olson L, Ungerstedt U. Mapping out of catecholamine and 5-hydroxytryptamine neurones innervating the telencephalon and diencephalon. Acta Physiol Scand. 1966;67:313–326
  12. Jouvet M. The role of monoamines and acetylcholine-containing neurones in the regulation of the sleep-waking cycle. Ergebn Physiol. 1972;64:166–307
  13. Jouvet M. Sleep and serotonin: an unfinished story. Neuropsychopharmacology. 1999;21:24S–27S
  14. Bouhuys AL, van den Hoofdakker R. Effects of midbrain raphe destruction on sleep and locomotor activity in rats. Physiol Behav. 1977;19:535–541
  15. Cespuglio R, Walker E, Gomez M-E, Musolino R. Cooling of the raphe nucleus induces sleep in the cat. Neurosci Lett. 1976;3:221–227
  16. Koella WP, Feldstein A, Czicman JS. The effect of para -chlorophenylalanine on the sleep of cats. Electroencephalogy Clin Neurophysiol. 1968;25:481–490
  17. Ursin R. Differential effect of para -chlorophenylalanine on the two slow wave sleep stages in the cat. Acta Physiol Scand. 1972;86:278–285
  18. Borbely AA, Neuhaus HU, Tobler I. Effect of p -chlorophenylalanine and tryptophan on sleep, EEG and motor activity in the rat. Behav Brain Res. 1981;2:1–22
  19. Pujol J-F, Buguet A, Froment J-L, Jones B, Jouvet M. The central metabolism of serotonin in the cat during insomnia. A neurophysiological and biochemical study after administration of p -chlorophenylalanine. Brain Res. 1971;29:195–212
  20. Ursin R, Bjorvatn B, Sommerfelt L, Underland G. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats. Behav Brain Res. 1989;34:117–130
  21. Dement WC, Mitler MM, Henriksen SJ. Sleep changes during chronic administration of parachlorophenylalanine. Rev Can Biol. 1972;31(Suppl.):239–246
  22. Ursin R. Does para -chlorophenylalanine produce disturbed waking, disturbed sleep or activation by ponto-geniculo-occipital waves in cats?. Waking Sleeping. 1980;4:2ll
  23. Ursin R. The effects of 5-hydroxytryptophan and L -tryptophan on wakefulness and sleep patterns in the cat. Brain Res. 1976;106:105–115
  24. Hartmann E, Cravens J, List S. Hypnotic effects of L -tryptophan. Arch Gen. Psychiatry. 1974;31:394–397
  25. Fernstrom JD. Can nutrient supplements modify brain function?. Am J Clin Nutr. 2000;71:1669S–1673S
  26. Spinweber LC, Ursin R, Hilderbrand RL. The effect of L -tryptophan: effects on daytime sleep latency and the waking EEG. Electroencephalogr Clin Neurophysiol. l983;55:652–666l
  27. Hajak G, Huether G, Blanke J. The influence of intravenous L -tryptophan on plasma melatonin and sleep in men. Pharmacopsyciatry. 1991;24:17–20
  28. Medsger TA. Tryptophan-induced eosinophilia myalgia syndrome. New Engl J Med. 1990;322:926–928
  29. Olsen ØE , Neckelmann D, Ursin R. Diurnal differences in L -tryptophan sleep and temperature effects in the rat. Behav Brain Res. 1994;65:195–203
  30. McGinty D, Harper RW. Dorsal raphe neurones: depression of firing during sleep in cats. Brain Res. 1976;101:569–575
  31. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioural arousal. Brain Res. 1979;163:135–150
  32. Cespuglio R, Faradji H, Gomez M-E, Jouvet M. Single unit recordings in the nuclei raphe dorsalis and magnus during the sleep–waking cycle of semi-chronic prepared cats. Neurosci Lett. 1981;24:133–138
  33. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev. 1992;72:165–229
  34. Guzmán-Marı́n R, Alam MN, Szymusiak R, Drucker-Colı́n R, Gong H, McGinty D. Discharge modulation of rat dorsal raphe neurones during sleep and waking: effects of preoptic/basal forbrain warming. Brain Res. 2000;875:23–34
  35. Portas CM, McCarley RW. Behavioural state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus: a microdialysis study in the freely moving cat. Brin Res. 1994;648:306–312
  36. Portas CM, Bjorvatn B, Fagerland S, Grønli J, Mundal V, Sørensen E, et al. On-line detection of extracellular levels of serotonin in dorsal raphe nucleus and frontal cortex over the sleep–wake cycle in the freely moving rat. Neuroscience. 1998;83:807–814
  37. Strecker RE, Thakkar MM, Porkka-Heiskanen T, Dauphin LJ, Bjørkum AA, McCarley RW. Behavioural state-related changes of extracellular serotonin concentration in the pedunculopontine tegmental nucleus: a microdialysis study in freely moving animals. Sleep Res Online. 1999;2:21–27
  38. Park SP, LopezRodriguez F, Wilson CL, Maidment N, Matsumoto Y, Engel J. In vivo microdialysis measures of extracellular serotonin in the rat hippocampus during sleep–wakefulness. Brain Res. 1999;833:291–296
  39. Cespuglio R, Sarda N, Gharib A, Chastrette N, Houdouin F, Rampin C, et al. Voltammetric Detection of the release of 5-hydroxyindole compounds throughout the sleep–waking cycle of the rat. Exp Brain Res. 1990;80:121–128
  40. Nitz D, Siegel J. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am J Physiol. 1997;273:R451–R455
  41. Levine ES, Jacobs BL. Neurochemical afferents controlling the activity of serotonergic neurones in the dorsal raphe nucleus – microiontophoretic studies in the awake cat. J Neurosci. 1992;12:4037–4044
  42. Mignot E. Perspectives in narcolepsi and hypocretin (orexin) research. Sleep Med. 2000;1:87–90
  43. Vogel G, Cohen J, Mullis D, Kensler T, Kaplita S. Nefazodone and REM sleep: how do antidepressant drugs decrease REM sleep?. Sleep. 1998;21:70–77
  44. Simon GE, Grothaus L, Katon W, Revicki D. Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine. J Clin Psychiatry. 1998;59:49–55
  45. Hilakivi I, Kovala T, Leppavuori A, Shvaloff A. Effects of serotonin and noradrenaline uptake blockers on wakefulness and sleep in cats. Pharmacol Toxicol. 1987;60:161–166
  46. Sommerfelt L, Ursin R. Behavioural, sleep–waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats. Behav Brain Res. 1991;45:105–115
  47. Sommerfelt L, Ursin R. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats. Behav Brain Res. 1987;24:1–10
  48. Ursin R, Bjorvatn B. Sleep–wake and EEG effects following adenosine A1 agonism and antagonism: similarities and interactions with sleep–wake and EEG effects following a serotonin reuptake inhibitor in rats. Sleep Res Online. 1998;1:117–119
  49. Bjørkum AA, Bjorvatn B, Neckelmann D, Ursin R. Sleep effects following intrathecal administration of the 5-HT1A agonist 8-OH-DPAT and the NMDA antagonist AP-5 in rats. Brain Res. 1995;692:251–258
  50. Peroutka SJ. 5-Hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. Trends Neurosci. 1988;11:496–500
  51. Idzikowski C, Mills FJ, Glennard R. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep. Brain Res. 1986;378:164–168
  52. Dugovic C, Wauquier A. 5-HT2 receptors could be primarily involved in the regulation of slow wave sleep in the rat. Eur J Pharmacol. 1987;137:145–146
  53. Sommerfelt L, Ursin R. The 5-HT2 antagonist ritanserin decreases sleep in cats. Sleep. 1993;16:15–22
  54. Bjorvatn B, Ursin R. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats. Behav Brain Res. 1990;40:239–246
  55. Borbèly AA, Trachsel L, Tobler I. Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol. 1988;156:275–278
  56. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science. 1993;262:679–685
  57. Lee KH, McCormick DA. Abolition of spindle oscillations by serotonin and norepinephrine in the ferret lateral geniculate and periogeniculate nuclei in vitro. Neuron. 1996;17:309–321
  58. Portas CM, Thakkar M, Rainnie D, McCarley RW. Microdialysis perfusion of 8-hydroxy-2-(di- n -propylamino) tetralin (8-OH-DPAT) in the dorsal raphe nucleus decreases serotonin release and increase rapid eye movement sleep in the freely moving cat. J Neurosci. 1996;16:2820–2828
  59. Bjorvatn B, Fagerland , S , Eid T, Ursin R. Sleep/waking effects of a selective 5-HT11A receptor agonist given systemically as well as perfused in dorsal raphe nucleus in rats. Brain Res. 1997;770:81–88
  60. Seifritz E, Moore P, Trachsel L, Bhatti T, Stahl SM, Gillin JC. The 5-HT11A agonist ipsapirone enhances EEG slow wave activity in human sleep and produces a power spectrum similar to 5-HT2 blockade. Neurosci Lett. 1996;209:41–44
  61. Tissier, M-H, Lainey, E, Fattaccini, C-M, Hamon, M, Adrien, J, Effects of ipsapirone, a 5-HT11A agonist, on sleep/wakefulness cycles: probable post-synaptic action, J Sleep Res 1993, 2, 103, 109
  62. Khateb A, Fort P, Alonso A, Jones BE. Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurones. Eur J Neurosci. 1993;5:541–547
  63. Szymusiak R. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. Sleep. 1995;18:478–500
  64. Nauta WJH. Hypothalamic regulation of sleep in rats. An experimental study. J Neurophysiol. 1946;9:285–316
  65. Sterman MB, Clemente C. Forebrain inhibitory mechanisms: sleep patterns induced by basal forebrain stimulation. Exp Neurol. 1962;6:103–117
  66. McGinty DJ, Sterman MB. Sleep suppression after basal forebrain lesions in the cat. Science. 1968;160:1253–1255
  67. Szymusiak R, Alam N, Steinnger T, McGinty D. Sleep–waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res. 1998;803:178–188
  68. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurones during sleep. Science. 1996;271:216–219
  69. Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci. 2000;20:3830–3842
  70. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurones by GABAergic and galaninergic neurones in the ventrolateral preoptic nucleus of the rat. J Neurosci. 1998;18:4705–4721
  71. Gallopin T, Fort P, Eggermann E. Identification of sleep-promoting neurones. Nature. 2000;404:992–995
  72. Bjørkum AA, Ha QH, Saper CB. Afferents to and efferents from the raphe nuclei to the ventrolateral preoptic nucleus. Soc Neurosci. 1999;25:675
  73. Gervasoni D, Peyron C, Rampon C, Barbagli B, Chouvet G, Urbain N, et al. Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurones. J Neurosci. 2000;20:4217–4225
  74. Semba K, Reiner PB, McGeer EG, Fibiger HC. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J Comp Neurol. 1988;267:433–453
  75. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjørkum AA, Green RW, McCarley RW. Adenosine; a mediator of the sleep-inducing effects of prolonged wakefulness. Science. 1997;276:1265–1268
  76. Brundege JM, Dunwiddie TV. Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol. 1997;39:351–391
  77. Okada M, Kawata Y, Kiryu K, Mizuno K, Wada K, Tasaki H, et al. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. J Neurochem. 1997;69:2581–2588
  78. Chemelli RM, Willie JT, Sinton CM. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437–451
  79. Peyron C, Tighe DK, vandenPol AN, deLecea L, Heller HC, Sutcliffe JG, et al. Neurones containing hypocretin (orexin) project to multiple neuroneal systems. J Neurosci. 1998;18:9996–10015
  80. Hagan JJ, Leslie RA, Patel S. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci. 1999;96:10911–10916
  81. Bourgin P, Huitronresendiz S, Spider AD. Hypocretin-1 modulates rapid eye movment sleep through activation of locus coeruleus neurons. J Neurosci. 2000;20:7760–7765
  82. Balsa JA, Sánchez-Franco F, Pazos F, Lara JI, Lorenzo , MJ , et al. Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior or posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide. Neuroendocrinology. 1998;68:326–333
  83. Roky R, Obal F, Valatx J-L, Bredow S, Fang J, Pagano L-P, et al. Prolactin and eye movement sleep regulation. Sleep. 1995;18:536–542
  84. Risold PY, Griffond B, Kilduff TF, Sutcliffe JG, Fellman D. Preprohypocretin (orexin) and prolactin-like immunoreactivity are coexpressed by neurons of the rat lateral hypothalamic area. Neurosci Lett. 1999;259:153–156
  85. Mistlberger RE. Behavioral and serotonergic regulation of circadian rhythms. Biol Rhythm Res. 2000;31:240–283
  86. Prosser R. Serotonergic actions and interactions on the SCN circadian pacemakers:. Biol Rhythm Res. 2000;31:315–339
  87. Sun X, Rusak B, Semba K. Electrophysiology and pharmacology of projections from the suprachiasmatic nucleus to the ventromedial preoptic area in rat. Neuroscience. 2000;98:715–728
  88. McCormick DA. Neurotransmittor actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity. Prog Neurobiol. 1992;39:337–388
  89. Destexhe A, Contreras D, Sejnowski TJ, Steriade M. Modeling the control of reticular thalamic oscillations by neuromodulators. Neuroreport. 1994;5:2217–2220
  90. Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuroneal groups. Science. 1975;189:55–58
  91. McCarley RW, Greene RW, Rainnie D, Portas CM. Brainstem neurmodulation and REM sleep. Semin Neurosci. 1995;7:341–354
  92. Siegel JM. Brainstem mechanisms generating REM sleep. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and Practice of Sleep Medicine. Philadelphia: WB Saunders; 1994;p. 125–144
  93. Honda T, Semba K. Serotonergic synaptic input to cholinergic neurons in the rat mesopontine tegmentum. Brain Res. 1994;647:299–306
  94. Thakkar M, Portas C, McCarley RW. Chronic low-amplitude electrical stimulation of the laterodorsal tegmental nucleus of freely moving cats increases REM sleep. Brain Res. 1996;723:223–227
  95. Thakkar MM, Strecker RE, McCarley RW. Behavioral state control through differential serotonergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci. 1998;18:5490–5497
  96. Horner RL, Sanford LD, Annis D, Pack AI, Morrison AR. Serotonin at the laterodorsal tegemental nucleus suppresses rapid- eye-movement sleep in freely behaving rats. J Neurosci. 1997;17:7541–7552
  97. Sørensen E, Bjorvatn B, Ursin R. Sleep–wake effects following the selective 5-HT1A receptor antagonist p-MPPI in the freely moving rat. Behav Brain Res. 2000;114:31–38
  98. Sakai K. Executive mechanisms of paradoxical sleep. Arch Ital Biol. 1988;126:239–257
  99. Shouse MN, Siegel JM. Pontine regulation of REM-sleep components in cats – integrity of the pedunculopontine tegmentum (PPT) is important for phasic events but unnecessary for atonia during REM-sleep. Brain Res. 1992;571:50–63
  100. Crochet S, Sakai K. Effect of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci. 1999;11:3738–3752
  101. Burlet S, Leger L, Cespuglio R. Nitric oxide and sleep in the rat: a puzzling relationship. Neurosci Lett. 1999;92:627–639
  102. Smith JCE, Whitton PS. Nitric oxide modulates. N -methyl- D -asparate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci Lett. 2000;291:5–8
  103. Leonard, TO, Lydic, R, Pontine nitric oxide modulates acetylcholine release, rapid eye movement sleep generation, and respiratory rate, J Neurosci, 17, 774, 785

PII: S1087-0792(01)90174-1

doi: 10.1053/smrv.2001.0174

Sleep Medicine Reviews
Volume 6, Issue 1 , Pages 55-67 , February 2002

Article Tools